BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38035852)

  • 21. [A Case of Initially Unresectable Advanced Gastric Cancer Radically Resected by Conversion Surgery after Nivolumab Immunotherapy].
    Koizumi N; Kashiwagi S; Ogino S; Kamada Y; Fujiki H; Sakakura C
    Gan To Kagaku Ryoho; 2020 Nov; 47(11):1624-1626. PubMed ID: 33268741
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A case of metastatic gastric cancer showing long-term control with nivolumab after pseudoprogression].
    Okamoto T; Ueda S
    Nihon Shokakibyo Gakkai Zasshi; 2021; 118(6):549-554. PubMed ID: 34108354
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A Case of Recurrent Gastric Cancer with Durable Complete Response after Short-Term Nivolumab Therapy].
    Yamamichi K; Yamada M; Sumiyama F; Yamamoto N; Hashimoto Y; Satake R; Hatta M; Sakaguchi T; Kotsuka M; Tokuhara K; Inoue K; Sekimoto M
    Gan To Kagaku Ryoho; 2021 Dec; 48(13):2052-2054. PubMed ID: 35045490
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A Case of Gastric Cancer Performed Curative Operation after Nivolumab].
    Tamesa T; Sakai B; Suzuki A; Iwamoto R; Tokunou K; Kawaoka T; Miyahara M; Yamashita Y; Yamamoto S
    Gan To Kagaku Ryoho; 2022 Dec; 49(13):1443-1445. PubMed ID: 36733096
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Long-Term Survival of a Patient with Para-Aortic Lymph Node Recurrence Who Underwent Lymph Node Dissection and Received Chemotherapy Following Curative Gastrectomy].
    Noro H; Hirao T; Teranishi R; Shimura Y; Todo M; Ohashi T; Osawa H; Sakai K; Yasumasa K; Iwasaki T; Hatanaka N; Yamasaki Y
    Gan To Kagaku Ryoho; 2019 Apr; 46(4):745-747. PubMed ID: 31164522
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neoadjuvant Nivolumab Plus Ipilimumab and Adjuvant Nivolumab in Localized Deficient Mismatch Repair/Microsatellite Instability-High Gastric or Esophagogastric Junction Adenocarcinoma: The GERCOR NEONIPIGA Phase II Study.
    André T; Tougeron D; Piessen G; de la Fouchardière C; Louvet C; Adenis A; Jary M; Tournigand C; Aparicio T; Desrame J; Lièvre A; Garcia-Larnicol ML; Pudlarz T; Cohen R; Memmi S; Vernerey D; Henriques J; Lefevre JH; Svrcek M
    J Clin Oncol; 2023 Jan; 41(2):255-265. PubMed ID: 35969830
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A Case of Recurrent Gastric Cancer with Long-Term Control via Two Resections and Multidisciplinary Treatment Including Nivolumab].
    Bungo M; Takeno A; Hirao M; Hamakawa T; Yamamoto M; Matsui Y; Tokuyama S; Toshiyama R; Kawai K; Takahashi Y; Sakai K; Doi T; Goto K; Kato T; Takami K
    Gan To Kagaku Ryoho; 2023 Dec; 50(13):1715-1717. PubMed ID: 38303183
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term survival after immunotherapy and targeted therapy without chemotherapy in an elderly patient with HER2-positive gastroesophageal junction cancer: A case report.
    Li WL; Zhang Y; Zhang XL; Du YY; Hu WQ; Zhao J
    Hum Vaccin Immunother; 2022 Nov; 18(6):2121109. PubMed ID: 36166751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A Case of Esophagogastric Junction Adenocarcinoma with Neuroendocrine Differentiation].
    Kitano Y; Kinoshita J; Oyama K; Okamoto K; Sakai S; Makino I; Nakamura K; Hayashi H; Inokuchi M; Miyashita T; Tajima H; Takamura H; Ninomiya I; Fushida S; Ohta T
    Gan To Kagaku Ryoho; 2017 Nov; 44(12):1226-1228. PubMed ID: 29394589
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nivolumab plus chemotherapy versus placebo plus chemotherapy in patients with HER2-negative, untreated, unresectable advanced or recurrent gastric or gastro-oesophageal junction cancer (ATTRACTION-4): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial.
    Kang YK; Chen LT; Ryu MH; Oh DY; Oh SC; Chung HC; Lee KW; Omori T; Shitara K; Sakuramoto S; Chung IJ; Yamaguchi K; Kato K; Sym SJ; Kadowaki S; Tsuji K; Chen JS; Bai LY; Oh SY; Choda Y; Yasui H; Takeuchi K; Hirashima Y; Hagihara S; Boku N
    Lancet Oncol; 2022 Feb; 23(2):234-247. PubMed ID: 35030335
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A Case of Neuroendocrine Carcinoma of the Stomach Treated with TAS-102].
    Nishio K; Kumazawa I; Tanaka K; Sano H; Goto A; Mizuno M; Fukada M
    Gan To Kagaku Ryoho; 2022 Oct; 49(10):1109-1111. PubMed ID: 36281604
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A Case of Long-Term Survival in a Patient with Lung Metastasis of Gastric Cancer Treated Using Curative Surgery].
    Namikawa T; Tsuda S; Fujisawa K; Munekage E; Iwabu J; Uemura S; Tsujii S; Maeda H; Kitagawa H; Kumon T; Nagata Y; Kobayashi M; Hanazaki K
    Gan To Kagaku Ryoho; 2018 Dec; 45(13):1827-1829. PubMed ID: 30692367
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Long-Term Survival of Gastric Cancer with Multiple Liver and Lymph Node Metastases-A Case Report].
    Ami K; Yamashita D; Yamada A; Kajiyama D; Kawaguchi M; Maeda F; Motoyama K; Amagasa H; Ganno H; Imai K; Iida S; Fukuda A; Akita H; Tei S; Andou M
    Gan To Kagaku Ryoho; 2019 Dec; 46(13):2467-2469. PubMed ID: 32156967
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Long-Term Complete Response by CapeOX plus Nivolumab Chemotherapy for Postoperative Recurrence of Gastric Cancer-A Case Report].
    Katsuyama S; Masuzawa T; Sugimura K; Yanagisawa K; Shinke G; Kinoshita M; Ikeshima R; Hiraki M; Ohmura Y; Hata T; Takeda Y; Murata K
    Gan To Kagaku Ryoho; 2024 Mar; 51(3):326-328. PubMed ID: 38494820
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimal surgical management for esophagogastric junction carcinoma.
    Matsuda T; Takeuchi H; Tsuwano S; Nakamura R; Takahashi T; Wada N; Kawakubo H; Saikawa Y; Omori T; Kitagawa Y
    Gen Thorac Cardiovasc Surg; 2014 Sep; 62(9):560-6. PubMed ID: 24570201
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nivolumab exerts therapeutic effects against metastatic lesions from early gastric adenocarcinoma with a small proportion of neuroendocrine carcinoma after gastrectomy: a case report.
    Sawayama H; Komohara Y; Hirao H; Sakata K; Takata N; Yoshinaka I; Harada K; Baba H
    Clin J Gastroenterol; 2020 Oct; 13(5):759-765. PubMed ID: 32592148
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A Case of Long-Term Progress Control of Unresectable Progressive Gastric Cancer with Nivolumab Introduced during Effective Duration of Secondary Treatment].
    Eguchi S; Akamaru Y; Wada N; Shimaoka T; Harada S; Ikeshima R; Munakata K; Takiuchi D; Hama N; Ota H; Shibata K
    Gan To Kagaku Ryoho; 2021 Dec; 48(13):2045-2047. PubMed ID: 35045488
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Solitary metastasis to a superior mediastinal lymph node after distal gastrectomy for gastric cancer: a case report.
    Kubo N; Yoshizawa J; Hanaoka T
    BMC Cancer; 2018 Jun; 18(1):627. PubMed ID: 29866101
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Two Cases of Alpha-Fetoprotein Producing Gastric Cancer].
    Tazuma S; Tatsumoto N; Kobayashi T; Hashizume J; Akayama K; Muto T; Okano K; Kondo Y; Nishikage T; Kuniyasu H
    Gan To Kagaku Ryoho; 2020 Dec; 47(13):2018-2020. PubMed ID: 33468786
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Three Cases of No. 16 Lymph Node Metastasis-Positive Gastric Cancer Successfully Treated with Chemotherapy and Para-Aortic Lymph Node Dissection].
    Tamaki S; Taniguchi K; Katsuragawa H; Hataji K; Okamoto F; Hayashi T; Ishii M; Tateno Y; Kanada Y; Yagi M
    Gan To Kagaku Ryoho; 2021 Dec; 48(13):2048-2051. PubMed ID: 35045489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.